When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ASCLF - Galmed collaborates with Gannex Pharma for development programs in NASH
Ascletis Pharma Inc.
Galmed Pharmaceuticals (NASDAQ:GLMD) anf Gannex Pharma, a wholly owned company of Ascletis Pharma Inc. (OTCPK:ASCLF) have entered into a research agreement aiming at combination therapy of ASC41 (THR-beta agonist) and Aramchol (SCD 1 inhibitor) for the treatment of non-alcoholic steatohepatitis (NASH).
More news on: Galmed Pharmaceuticals Ltd., Ascletis Pharma Inc., Healthcare stocks news,